These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8424594)

  • 1. Management of the patient with IgG subclass deficiency and/or selective antibody deficiency.
    Herrod HG
    Ann Allergy; 1993 Jan; 70(1):3-8. PubMed ID: 8424594
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated IgG3 deficiency in children: to treat or not to treat? Case presentation and review of the literature.
    Meyts I; Bossuyt X; Proesmans M; De B
    Pediatr Allergy Immunol; 2006 Nov; 17(7):544-50. PubMed ID: 17014632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG.
    Chua I; Lagos M; Charalambous BM; Workman S; Chee R; Grimbacher B
    J Allergy Clin Immunol; 2011 Jun; 127(6):1410-1. PubMed ID: 21376379
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of intravenous gammaglobulin for immunoglobulin G subclass and/or antibody deficiency in adults.
    Abdou NI; Greenwell CA; Mehta R; Narra M; Hester JD; Halsey JF
    Int Arch Allergy Immunol; 2009; 149(3):267-74. PubMed ID: 19218820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG subclass deficiency.
    Preud'homme JL; Hanson LA
    Immunodefic Rev; 1990; 2(2):129-49. PubMed ID: 2223061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment and management of primary antibody deficiency.
    Empson M; Sinclair J; O'Donnell J; Ameratunga R; Fitzharris P; Steele R;
    N Z Med J; 2004 Jun; 117(1195):U914. PubMed ID: 15282626
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
    Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
    Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of infections in primary and secondary antibody deficiency].
    Mikołuć B; Pietrucha B; Motkowski R; Wolska-Kuśnierz B; Heropolitańska-Pliszka E; Bernatowska E
    Przegl Epidemiol; 2009; 63(1):55-60. PubMed ID: 19522227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of IgG subclass deficiency with the initial presentation of transient hypogammaimmuno-globulinemia of infancy and a review of IgG subclass deficiencies.
    Nettagul R; Visitsunthorn N; Vichyanond P
    J Med Assoc Thai; 2003 Jul; 86(7):686-92. PubMed ID: 12948264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency.
    Kutukculer N; Karaca NE; Demircioglu O; Aksu G
    Pediatr Allergy Immunol; 2007 Mar; 18(2):167-73. PubMed ID: 17338791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin therapy: the process, the product, the patient, and the pocketbook. Introduction.
    Harvey RD
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):71S-72S. PubMed ID: 16229676
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy.
    Atarod L; Aghamohammadi A; Moin M; Kanegane H; Rezaei N; Rezaei Kalantari K; Amirzagar AA; Futatani T; Miyawaki M
    Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):37-40. PubMed ID: 17303928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of IVIG in secondary immunodeficiencies].
    Zeman K; Lewandowicz-Uszyńska A
    Postepy Hig Med Dosw; 2002; 56 Suppl():91-102. PubMed ID: 12661419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous immunoglobulin infusion to treat infants and toddlers with antibody deficiencies.
    Meth MJ; Rosenthal DW; Bonagura VR
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):187-8. PubMed ID: 20674834
    [No Abstract]   [Full Text] [Related]  

  • 15. [Substitution therapy for deficiencies in antibody production by immunoglobulins].
    Strengers PF
    Arch Pediatr; 1999; 6 Suppl 2():423s-424s. PubMed ID: 10370557
    [No Abstract]   [Full Text] [Related]  

  • 16. Giving intravenous immunoglobulin.
    Scherf R; White-Reid K
    RN; 2008 Jan; 71(1):29-34; quiz 35. PubMed ID: 18271361
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective controlled crossover trial of a new presentation (10% vs. 5%) of a heat-treated intravenous immunoglobulin.
    Matamoros N; De Gracia J; Hernández F; Pons J; Alvarez A; Jiménez V
    Int Immunopharmacol; 2005 Mar; 5(3):619-26. PubMed ID: 15683857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravenous immunoglobulins in dermatology].
    Nydegger U; Hunziker T
    Ann Dermatol Venereol; 2002; 129(8-9):1078-81. PubMed ID: 12442118
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy recommendations for the use of intravenously applicable immunoglobulins].
    Marschner JP; Rietbrock N
    Med Klin (Munich); 1996 Mar; 91(3):141-7. PubMed ID: 8628200
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of antibody deficiency syndromes.
    Schuval SJ
    Pediatr Rev; 2000 Oct; 21(10):358-9. PubMed ID: 11010985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.